Introduction: Graft versus host disease (GvHD) prophylaxis impacts on post–hematopoietic stem cell transplantation (HSCT) immune reconstitution (IR). Specifically, anti-T lymphocyte globulin (ATLG) delays CD4+ T cell reconstitution. However, the mechanism by which ATLG alters the composition of CD4+ T-cell compartments remains elusive. Aims: Dissect the impact of ATLG on CD4+ T cells by integrating advanced and highly standardized flow cytometric panels, unsupervised clustering analysis, machine learning approaches, and molecular biology techniques. Results: We analyzed post-HSCT IR in 94 pediatric patients with a machine learning approach. ATLG exposure resulted in the most relevant variable affecting CD4+ T-cell counts. Severe combined immunodeficiency/recent thymic emigrant (SCID/RTE) and CD4 PERISCOPE EuroFlow antibody panels were applied to a sub-cohort of patients with acute lymphoblastic leukemia. Unsupervised clustering analysis showed that in the first months, post-HSCT CD4+ naïve T cells and RTEs were significantly reduced in ATLG-treated compared to no-ATLG patients, including haploidentical graft recipients receiving post-transplant cyclophosphamide. In no-ATLG patients, there was a significant contribution of residual recipient-derived cells to the RTE compartment, whereas in ATLG-treated patients RTEs were of donor origin. In addition, in no-ATLG patients, early RTEs and CD4+ T-cell counts correlated with infused CD3+ T cells/kg. Bone marrow and T-cell receptor excision circle (TREC) analysis showed that ATLG treatment does not affect early T-cell maturation. In vitro testing showed increased differentiation of naïve/RTE CD4+ into effector subsets upon ATLG exposure, confirmed by flow cytometry and RNA sequencing. Discussion: Our data show that ATLG induces concomitant differentiation and depletion of the peripheral CD4+ naïve/RTE T-cell compartment. Together, these findings suggest that naïve T-cell reconstitution after ATLG is delayed since it only relies on thymic maturation, differently from no-ATLG treated patients.
Sindoni, M., Toso, A., Limido, F., Bugarin, C., Villa, T., Bonte, S., et al. (2025). Impact of ATLG on CD4+ T-cell reconstitution after HSCT in children: a detailed immune profiling study. CYTOTHERAPY, 27(10), 1208-1218 [10.1016/j.jcyt.2025.06.009].
Impact of ATLG on CD4+ T-cell reconstitution after HSCT in children: a detailed immune profiling study
Sindoni M. M.;Toso A.;Limido F.;Buracchi C.;Prunotto G.;Sala S.;Fazio G.;Biondi A.;Balduzzi A.;Nucera S.;Gaipa G.
2025
Abstract
Introduction: Graft versus host disease (GvHD) prophylaxis impacts on post–hematopoietic stem cell transplantation (HSCT) immune reconstitution (IR). Specifically, anti-T lymphocyte globulin (ATLG) delays CD4+ T cell reconstitution. However, the mechanism by which ATLG alters the composition of CD4+ T-cell compartments remains elusive. Aims: Dissect the impact of ATLG on CD4+ T cells by integrating advanced and highly standardized flow cytometric panels, unsupervised clustering analysis, machine learning approaches, and molecular biology techniques. Results: We analyzed post-HSCT IR in 94 pediatric patients with a machine learning approach. ATLG exposure resulted in the most relevant variable affecting CD4+ T-cell counts. Severe combined immunodeficiency/recent thymic emigrant (SCID/RTE) and CD4 PERISCOPE EuroFlow antibody panels were applied to a sub-cohort of patients with acute lymphoblastic leukemia. Unsupervised clustering analysis showed that in the first months, post-HSCT CD4+ naïve T cells and RTEs were significantly reduced in ATLG-treated compared to no-ATLG patients, including haploidentical graft recipients receiving post-transplant cyclophosphamide. In no-ATLG patients, there was a significant contribution of residual recipient-derived cells to the RTE compartment, whereas in ATLG-treated patients RTEs were of donor origin. In addition, in no-ATLG patients, early RTEs and CD4+ T-cell counts correlated with infused CD3+ T cells/kg. Bone marrow and T-cell receptor excision circle (TREC) analysis showed that ATLG treatment does not affect early T-cell maturation. In vitro testing showed increased differentiation of naïve/RTE CD4+ into effector subsets upon ATLG exposure, confirmed by flow cytometry and RNA sequencing. Discussion: Our data show that ATLG induces concomitant differentiation and depletion of the peripheral CD4+ naïve/RTE T-cell compartment. Together, these findings suggest that naïve T-cell reconstitution after ATLG is delayed since it only relies on thymic maturation, differently from no-ATLG treated patients.| File | Dimensione | Formato | |
|---|---|---|---|
|
Sindoni et al-2025-Cytotherapy-VoR.pdf
accesso aperto
Descrizione: This is an open access article under the CC BY-NC-ND license
Tipologia di allegato:
Publisher’s Version (Version of Record, VoR)
Licenza:
Creative Commons
Dimensione
2.66 MB
Formato
Adobe PDF
|
2.66 MB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


